Sheeja T Pullarkat

Summary

Affiliation: University of California
Country: USA

Publications

  1. pmc Diagnostic confusion resulting from CD56 expression by cutaneous myeloid sarcoma
    Thanh Ho
    Department of Pathology and Laboratory Medicine and
    Rare Tumors 1:e51. 2009
  2. ncbi request reprint Systemic mastocytosis with plasma cell dyscrasia: report of a case
    Sheeja T Pullarkat
    Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA, 10833 Le Conte Avenue, Los Angeles, CA 90095, United States
    Leuk Res 32:1160-3. 2008
  3. doi request reprint Megakaryocytic blast crisis as a presenting manifestation of chronic myeloid leukemia
    Sheeja T Pullarkat
    Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, United States
    Leuk Res 32:1770-5. 2008
  4. pmc High lifetime incidence of adult acute lymphoblastic leukemia among Hispanics in California
    Sheeja T Pullarkat
    Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095 1732, USA
    Cancer Epidemiol Biomarkers Prev 18:611-5. 2009
  5. pmc Systemic mastocytosis associated with t(8;21)(q22;q22) acute myeloid leukemia
    Sheeja T Pullarkat
    Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA, 10833 Le Conte Avenue, CHS, A7 149, Los Angeles, CA, 90095 1732, USA
    J Hematop 2:27-33. 2009
  6. doi request reprint Characterization of bone marrow mast cells in acute myeloid leukemia with t(8;21) (q22;q22); RUNX1-RUNX1T1
    Sheeja T Pullarkat
    Department of Pathology and Laboratory Medicine, UCLA David Geffen School of Medicine, Los Angeles, CA, United States
    Leuk Res 37:1572-5. 2013
  7. ncbi request reprint Systemic mastocytosis with associated clonal hematological non-mast-cell lineage disease: analysis of clinicopathologic features and activating c-kit mutations
    Vinod A Pullarkat
    Division of Hematology, University of Southern California Keck School of Medicine, Los Angeles, CA, USA
    Am J Hematol 73:12-7. 2003
  8. ncbi request reprint KSHV/HHV8-negative effusion-based lymphoma, a distinct entity associated with fluid overload states
    Serge Alexanian
    David Geffen School of Medicine at UCLA, CA, USA
    Am J Surg Pathol 37:241-9. 2013
  9. ncbi request reprint Strong expression of chemokine receptor CCR9 in diffuse large B-cell lymphoma and follicular lymphoma strongly correlates with gastrointestinal involvement
    Winnie Wu
    Department of Pathology, University of California Los Angeles UCLA David Geffen School of Medicine, Los Angeles, CA, 90095 1732, USA
    Hum Pathol 45:1451-8. 2014
  10. ncbi request reprint Risk of lymphoma in patients receiving antitumor necrosis factor therapy: a meta-analysis of published randomized controlled studies
    Anna K Wong
    Department of Pathology and Laboratory Medicine, UCSD School of Medicine, San Diego, CA, USA
    Clin Rheumatol 31:631-6. 2012

Collaborators

Detail Information

Publications11

  1. pmc Diagnostic confusion resulting from CD56 expression by cutaneous myeloid sarcoma
    Thanh Ho
    Department of Pathology and Laboratory Medicine and
    Rare Tumors 1:e51. 2009
    ..Aberrant antigen expression by cutaneous myeloid sarcomas can cause diagnostic confusion with other cutaneous neoplasms. This is especially relevant when myeloid sarcoma is the sole manifestation of acute myeloid leukemia...
  2. ncbi request reprint Systemic mastocytosis with plasma cell dyscrasia: report of a case
    Sheeja T Pullarkat
    Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA, 10833 Le Conte Avenue, Los Angeles, CA 90095, United States
    Leuk Res 32:1160-3. 2008
    ..We also discuss the pathologic interaction between the neoplastic mast cells of SM and the lymphoid/plasma cell malignancy when these two entities coexist...
  3. doi request reprint Megakaryocytic blast crisis as a presenting manifestation of chronic myeloid leukemia
    Sheeja T Pullarkat
    Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, United States
    Leuk Res 32:1770-5. 2008
    ..Blast crisis as a presenting manifestation of CML is rare and detecting clonal evolution of acute leukemia by specialized cytogenetic techniques may have important diagnostic and therapeutic implications...
  4. pmc High lifetime incidence of adult acute lymphoblastic leukemia among Hispanics in California
    Sheeja T Pullarkat
    Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095 1732, USA
    Cancer Epidemiol Biomarkers Prev 18:611-5. 2009
    ..The higher incidence of acute lymphoblastic leukemia (ALL) among Hispanic children relative to that in other racial/ethnic groups is well-known. We evaluated the incidence patterns of ALL in adults...
  5. pmc Systemic mastocytosis associated with t(8;21)(q22;q22) acute myeloid leukemia
    Sheeja T Pullarkat
    Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA, 10833 Le Conte Avenue, CHS, A7 149, Los Angeles, CA, 90095 1732, USA
    J Hematop 2:27-33. 2009
    ..SM associated with t(8;21) AML carries a dismal prognosis; therefore, detection of concurrent SM at diagnosis of t(8;21) AML has important prognostic implications...
  6. doi request reprint Characterization of bone marrow mast cells in acute myeloid leukemia with t(8;21) (q22;q22); RUNX1-RUNX1T1
    Sheeja T Pullarkat
    Department of Pathology and Laboratory Medicine, UCLA David Geffen School of Medicine, Los Angeles, CA, United States
    Leuk Res 37:1572-5. 2013
    ..These findings confirm the shared origin between mast cells and leukemic blasts in AML with t(8;21). ..
  7. ncbi request reprint Systemic mastocytosis with associated clonal hematological non-mast-cell lineage disease: analysis of clinicopathologic features and activating c-kit mutations
    Vinod A Pullarkat
    Division of Hematology, University of Southern California Keck School of Medicine, Los Angeles, CA, USA
    Am J Hematol 73:12-7. 2003
    ..As clinically effective tyrosine kinase inhibitors that inhibit enzymatic-type c-kit mutations are being developed, detection of mast cell proliferation associated with myeloid malignancy may have important therapeutic implications...
  8. ncbi request reprint KSHV/HHV8-negative effusion-based lymphoma, a distinct entity associated with fluid overload states
    Serge Alexanian
    David Geffen School of Medicine at UCLA, CA, USA
    Am J Surg Pathol 37:241-9. 2013
    ..We suggest that HHV8-negative effusion-based lymphoma is a distinct entity associated with fluid overload states...
  9. ncbi request reprint Strong expression of chemokine receptor CCR9 in diffuse large B-cell lymphoma and follicular lymphoma strongly correlates with gastrointestinal involvement
    Winnie Wu
    Department of Pathology, University of California Los Angeles UCLA David Geffen School of Medicine, Los Angeles, CA, 90095 1732, USA
    Hum Pathol 45:1451-8. 2014
    ....
  10. ncbi request reprint Risk of lymphoma in patients receiving antitumor necrosis factor therapy: a meta-analysis of published randomized controlled studies
    Anna K Wong
    Department of Pathology and Laboratory Medicine, UCSD School of Medicine, San Diego, CA, USA
    Clin Rheumatol 31:631-6. 2012
    ..0928. There is a suggestion of increased lymphomas in the treated group, with the predominant subset being B-cell lymphomas. Since the outcome of lymphoma is rare, it does not reach statistical significance of p < 0.05...
  11. doi request reprint Adult leukemic synovitis is associated with leukemia of monocytic differentiation
    Sara C Acree
    Department of Pathology, University of Southern California Los Angeles County Medical Center, Los Angeles, CA, USA
    J Clin Rheumatol 17:130-4. 2011
    ..Leukemic synovitis is a rare complication of adult myeloid leukemias characterized by joint pain and swelling. It is important to recognize this diagnostic challenge as it may be the initial manifestation of leukemia or of relapse...